Your browser doesn't support javascript.
loading
Real-Life Prognosis of Sinonasal Tumors.
Pecorari, Giancarlo; Motatto, Gian Marco; Piazza, Federica; Garzaro, Alessandro; Riva, Giuseppe.
Affiliation
  • Pecorari G; Division of Otorhinolaryngology, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.
  • Motatto GM; Division of Otorhinolaryngology, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.
  • Piazza F; Division of Otorhinolaryngology, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.
  • Garzaro A; Division of Otorhinolaryngology, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.
  • Riva G; Division of Otorhinolaryngology, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.
J Pers Med ; 14(5)2024 Apr 24.
Article in En | MEDLINE | ID: mdl-38793026
ABSTRACT

BACKGROUND:

Sinonasal cancer represents a challenging disease because of its difficult diagnosis and different histology. Despite a multidisciplinary evaluation and treatments, a poor prognosis is still present. We retrospectively analyzed patients with sinonasal cancer treated in our institution, paying attention to histology and real-life prognosis.

METHODS:

A total of 51 consecutive patients were included in the study. Clinical features were described. Overall, disease-free, and disease-specific survival (OS, DFS, DSS) according to histology were calculated. Kaplan-Meyer estimator curves were reported.

RESULTS:

The most prevalent primary tumor was squamous cell carcinoma, followed by adenocarcinoma. Global 2- and 5-year OS was 68.80% and 54.58%, respectively. Global 2- and 5-year DFS was 48.53% and 29.56%, while global 2- and 5-year DSS was 82.86% and 74.57%, respectively. The median OS was 74 and 43 months for early- and late-stage cancer, respectively. The Cox multivariate regression analysis did not reveal any statistically significant effects of age, stage, or histology on survival outcomes.

CONCLUSIONS:

The diagnosis is often late and the prognosis poor. An appropriate treatment, which is always quite multimodal, allows us to achieve a global 5-year OS slightly higher than 50%. An adequate diagnosis to increase the percentage of early-stage tumors is mandatory to improve prognosis.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Pers Med Year: 2024 Document type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Pers Med Year: 2024 Document type: Article Affiliation country: Italy